Literature DB >> 15254952

Spinocerebellar ataxia type 2 with Levodopa-responsive parkinsonism culminating in motor neuron disease.

Jon Infante1, José Berciano1, Victor Volpini2, Jordi Corral2, José Miguel Polo1, Julio Pascual1, Onofre Combarros1.   

Abstract

We describe an exceptional spinocerebellar ataxia type 2 (SCA2) phenotype combining cerebellar ataxia, levodopa-responsive parkinsonism, and motor neuron symptoms. We conclude that motor neuron symptoms and signs may be a striking manifestation in SCA2, masking pre-existing cerebellar and extrapyramidal semeiology. Copyright 2004 Movement Disorder Society

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15254952     DOI： 10.1002/mds.20090

Source DB:  PubMed          Journal:  Mov Disord        ISSN： 0885-3185            Impact factor:   10.338


  20 in total

1.  Coexistence of Huntington's disease and amyotrophic lateral sclerosis: a clinicopathologic study.

Authors:  Mari Tada; Elizabeth A Coon; Alexander P Osmand; Patricia A Kirby; Wayne Martin; Marguerite Wieler; Atsushi Shiga; Hiroe Shirasaki; Masayoshi Tada; Takao Makifuchi; Mitsunori Yamada; Akiyoshi Kakita; Masatoyo Nishizawa; Hitoshi Takahashi; Henry L Paulson
Journal:  Acta Neuropathol       Date:  2012-06-27       Impact factor: 17.088

2.  Hereditary Ataxias in Cuba: A Nationwide Epidemiological and Clinical Study in 1001 Patients.

Authors:  Luis Velázquez-Pérez; Jacqueline Medrano-Montero; Roberto Rodríguez-Labrada; Nalia Canales-Ochoa; Jandy Campins Alí; Frank J Carrillo Rodes; Tania Rodríguez Graña; María O Hernández Oliver; Raul Aguilera Rodríguez; Yennis Domínguez Barrios; Reydenis Torres Vega; Lissi Flores Angulo; Noharis Y Cordero Navarro; Aldo A Sigler Villanueva; Osiel Gámez Rodríguez; Ilya Sagaró Zambrano; Nayime Y Navas Napóles; Javier García Zacarías; Orlando R Serrano Barrera; María B Ramírez Bautista; Annelié Estupiñán Rodríguez; Leonardo A Guerra Rondón; Yaimeé Vázquez-Mojena; Yanetza González-Zaldivar; Luis E Almaguer Mederos; Alejandro Leyva-Mérida
Journal:  Cerebellum       Date:  2020-04       Impact factor: 3.847

3.  Lisuride reduces involuntary periodic leg movements in spinocerebellar ataxia type 2 patients.

Authors:  Luis Velázquez-Pérez; Roberto Rodríguez-Labrada; Lázaro Álvarez-González; Raúl Aguilera-Rodríguez; Mario Álvarez Sánchez; Nalia Canales-Ochoa; Lourdes Galicia Polo; Reyes Haro-Valencia; Jacqueline Medrano-Montero; Yaimeé Vázquez-Mojena; Arnoy Peña-Acosta; Annelié Estupiñán-Rodríguez; Noemí Rodríguez Pupo
Journal:  Cerebellum       Date:  2012-12       Impact factor: 3.847

4.  Ataxin-2 repeat-length variation and neurodegeneration.

Authors:  Owen A Ross; Nicola J Rutherford; Matt Baker; Alexandra I Soto-Ortolaza; Minerva M Carrasquillo; Mariely DeJesus-Hernandez; Jennifer Adamson; Ma Li; Kathryn Volkening; Elizabeth Finger; William W Seeley; Kimmo J Hatanpaa; Catherine Lomen-Hoerth; Andrew Kertesz; Eileen H Bigio; Carol Lippa; Bryan K Woodruff; David S Knopman; Charles L White; Jay A Van Gerpen; James F Meschia; Ian R Mackenzie; Kevin Boylan; Bradley F Boeve; Bruce L Miller; Michael J Strong; Ryan J Uitti; Steven G Younkin; Neill R Graff-Radford; Ronald C Petersen; Zbigniew K Wszolek; Dennis W Dickson; Rosa Rademakers
Journal:  Hum Mol Genet       Date:  2011-05-24       Impact factor: 6.150

5.  Spinocerebellar ataxia type 2 is associated with Parkinsonism and Lewy body pathology.

Authors:  Masaki Takao; Masahiro Aoyama; Kinya Ishikawa; Yoshio Sakiyama; Harumi Yomono; Yuko Saito; Hiroshi Kurisaki; Ban Mihara; Shigeo Murayama
Journal:  BMJ Case Rep       Date:  2011-04-01

Review 6.  Frontotemporal dementia: a bridge between dementia and neuromuscular disease.

Authors:  Adeline S L Ng; Rosa Rademakers; Bruce L Miller
Journal:  Ann N Y Acad Sci       Date:  2014-12-30       Impact factor: 5.691

7.  ATXN-2 CAG repeat expansions are interrupted in ALS patients.

Authors:  Lucia Corrado; Letizia Mazzini; Gaia Donata Oggioni; Bernadetta Luciano; Michela Godi; Alfredo Brusco; Sandra D'Alfonso
Journal:  Hum Genet       Date:  2011-05-03       Impact factor: 4.132

Review 8.  Spinocerebellar ataxia 2 (SCA2).

Authors:  Isabel Lastres-Becker; Udo Rüb; Georg Auburger
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

Review 9.  Rare association of motor neuron disease and spinocerebellar ataxia type 2 (SCA2): a new case and review of the literature.

Authors:  Lorenzo Nanetti; Roberto Fancellu; Chiara Tomasello; Cinzia Gellera; Davide Pareyson; Caterina Mariotti
Journal:  J Neurol       Date:  2009-07-31       Impact factor: 4.849

10.  Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS.

Authors:  Andrew C Elden; Hyung-Jun Kim; Michael P Hart; Alice S Chen-Plotkin; Brian S Johnson; Xiaodong Fang; Maria Armakola; Felix Geser; Robert Greene; Min Min Lu; Arun Padmanabhan; Dana Clay-Falcone; Leo McCluskey; Lauren Elman; Denise Juhr; Peter J Gruber; Udo Rüb; Georg Auburger; John Q Trojanowski; Virginia M-Y Lee; Vivianna M Van Deerlin; Nancy M Bonini; Aaron D Gitler
Journal:  Nature       Date:  2010-08-26       Impact factor: 49.962
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.